Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | DiseaseId | DiseaseName | DiseaseMIM | ConceptID | Source | Typical association | HGMD variants | ClinVar variants | HGNC ID | GeneMIM |
---|
HPO disease - gene - phenotype typical associations: |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | BRCA1 CL E G H | 672 | 1333 | Chromosome 19, ring | | CN036553 | ORPHA | 1 | | 12586 | 1100 | 113705 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | BRCA1 CL E G H | 672 | 1333 | Chromosome 19, ring | | CN036553 | ORPHA | 1 | | 12207 | 1100 | 113705 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | BRCA2 CL E G H | 675 | 1333 | Chromosome 19, ring | | CN036553 | ORPHA | 1 | | 14742 | 1101 | 600185 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | BRCA2 CL E G H | 675 | 1333 | Chromosome 19, ring | | CN036553 | ORPHA | 1 | | 13912 | 1101 | 600185 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | CDC73 CL E G H | 79577 | 145001 | Hyperparathyroidism 2 | 145001 | C1704981 | OMIM | 1 | | 828 | 16783 | 607393 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | CDC73 CL E G H | 79577 | 145001 | Hyperparathyroidism 2 | 145001 | C1704981 | OMIM | 1 | | 704 | 16783 | 607393 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | CDKN2A CL E G H | 1029 | 1333 | Chromosome 19, ring | | CN036553 | ORPHA | 1 | | 1062 | 1787 | 600160 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | CDKN2A CL E G H | 1029 | 1333 | Chromosome 19, ring | | CN036553 | ORPHA | 1 | | 971 | 1787 | 600160 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | CDKN2A CL E G H | 1029 | 606719 | Melanoma-pancreatic cancer syndrome | 606719 | C1838547 | OMIM | 1 | | 1062 | 1787 | 600160 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | CDKN2A CL E G H | 1029 | 606719 | Melanoma-pancreatic cancer syndrome | 606719 | C1838547 | OMIM | 1 | | 971 | 1787 | 600160 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | KRAS CL E G H | 3845 | 1333 | Chromosome 19, ring | | CN036553 | ORPHA | 1 | | 341 | 6407 | 190070 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | KRAS CL E G H | 3845 | 1333 | Chromosome 19, ring | | CN036553 | ORPHA | 1 | | 331 | 6407 | 190070 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | PALB2 CL E G H | 79728 | 1333 | Chromosome 19, ring | | CN036553 | ORPHA | 1 | | 4245 | 26144 | 610355 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | PALB2 CL E G H | 79728 | 1333 | Chromosome 19, ring | | CN036553 | ORPHA | 1 | | 3925 | 26144 | 610355 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | PALLD CL E G H | 23022 | 1333 | Chromosome 19, ring | | CN036553 | ORPHA | 1 | | 614 | 17068 | 608092 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | PALLD CL E G H | 23022 | 1333 | Chromosome 19, ring | | CN036553 | ORPHA | 1 | | 546 | 17068 | 608092 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | SMAD4 CL E G H | 4089 | 1333 | Chromosome 19, ring | | CN036553 | ORPHA | 1 | | 1495 | 6770 | 600993 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | SMAD4 CL E G H | 4089 | 1333 | Chromosome 19, ring | | CN036553 | ORPHA | 1 | | 1359 | 6770 | 600993 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | TP53 CL E G H | 7157 | 1333 | Chromosome 19, ring | | CN036553 | ORPHA | 1 | | 2464 | 11998 | 191170 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | TP53 CL E G H | 7157 | 1333 | Chromosome 19, ring | | CN036553 | ORPHA | 1 | | 2280 | 11998 | 191170 |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | CDC73 CL E G H | 79577 | 99880 | | | | ORPHA | 0 | | 828 | 16783 | 607393 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | CDC73 CL E G H | 79577 | 99880 | | | | ORPHA | 0 | | 704 | 16783 | 607393 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | CDC73 CL E G H | 79577 | 143 | | | | ORPHA | 0 | | 828 | 16783 | 607393 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | CDC73 CL E G H | 79577 | 143 | | | | ORPHA | 0 | | 704 | 16783 | 607393 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | EPCAM CL E G H | 4072 | 144 | | | | ORPHA | 0 | | 374 | 11529 | 185535 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | EPCAM CL E G H | 4072 | 144 | | | | ORPHA | 0 | | 360 | 11529 | 185535 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | FAN1 CL E G H | 22909 | 144 | | | | ORPHA | 0 | | 361 | 29170 | 613534 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | FAN1 CL E G H | 22909 | 144 | | | | ORPHA | 0 | | 351 | 29170 | 613534 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | KRAS CL E G H | 3845 | 144 | | | | ORPHA | 0 | | 341 | 6407 | 190070 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | KRAS CL E G H | 3845 | 144 | | | | ORPHA | 0 | | 331 | 6407 | 190070 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | MLH1 CL E G H | 4292 | 144 | | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | MLH1 CL E G H | 4292 | 144 | | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | MLH3 CL E G H | 27030 | 144 | | | | ORPHA | 0 | | 763 | 7128 | 604395 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | MLH3 CL E G H | 27030 | 144 | | | | ORPHA | 0 | | 634 | 7128 | 604395 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | MSH2 CL E G H | 4436 | 144 | | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | MSH2 CL E G H | 4436 | 144 | | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | MSH6 CL E G H | 2956 | 144 | | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | MSH6 CL E G H | 2956 | 144 | | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | NTHL1 CL E G H | 4913 | 454840 | | | | ORPHA | 0 | | 902 | 8028 | 602656 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | NTHL1 CL E G H | 4913 | 454840 | | | | ORPHA | 0 | | 755 | 8028 | 602656 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | PIK3CA CL E G H | 5290 | 144 | | | | ORPHA | 0 | | 613 | 8975 | 171834 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | PIK3CA CL E G H | 5290 | 144 | | | | ORPHA | 0 | | 544 | 8975 | 171834 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | PMS1 CL E G H | 5378 | 144 | | | | ORPHA | 0 | | 92 | 9121 | 600258 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | PMS1 CL E G H | 5378 | 144 | | | | ORPHA | 0 | | 85 | 9121 | 600258 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | PMS2 CL E G H | 5395 | 144 | | | | ORPHA | 0 | | 3421 | 9122 | 600259 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | PMS2 CL E G H | 5395 | 144 | | | | ORPHA | 0 | | 3154 | 9122 | 600259 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | RNF43 CL E G H | 54894 | 157798 | | | | ORPHA | 0 | | 322 | 18505 | 612482 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | RNF43 CL E G H | 54894 | 157798 | | | | ORPHA | 0 | | 221 | 18505 | 612482 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | STK11 CL E G H | 6794 | 2869 | Hypertrophic osteoarthropathy, primary or idiopathic | | | ORPHA | 0 | | 1945 | 11389 | 602216 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | STK11 CL E G H | 6794 | 2869 | Hypertrophic osteoarthropathy, primary or idiopathic | | | ORPHA | 0 | | 1820 | 11389 | 602216 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | TGFBR2 CL E G H | 7048 | 144 | | | | ORPHA | 0 | | 750 | 11773 | 190182 |
HP:0006725 | HP:0006725 | Pancreatic adenocarcinoma | 0 | TGFBR2 CL E G H | 7048 | 144 | | | | ORPHA | 0 | | 694 | 11773 | 190182 |